329 related articles for article (PubMed ID: 16522150)
41. Liver cell models in in vitro toxicology.
Guillouzo A
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):511-32. PubMed ID: 9599700
[TBL] [Abstract][Full Text] [Related]
42. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
[TBL] [Abstract][Full Text] [Related]
43. Practical Aspects of Designing and Conducting Validation Studies Involving Multi-study Trials.
Coecke S; Bernasconi C; Bowe G; Bostroem AC; Burton J; Cole T; Fortaner S; Gouliarmou V; Gray A; Griesinger C; Louhimies S; Gyves EM; Joossens E; Prinz MJ; Milcamps A; Parissis N; Wilk-Zasadna I; Barroso J; Desprez B; Langezaal I; Liska R; Morath S; Reina V; Zorzoli C; Zuang V
Adv Exp Med Biol; 2016; 856():133-163. PubMed ID: 27671721
[TBL] [Abstract][Full Text] [Related]
44. The challenge of reproductive and developmental toxicology under REACH.
Scialli AR
Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
[TBL] [Abstract][Full Text] [Related]
45. The principles of validation and the ECVAM validation process.
Worth AP; Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
[TBL] [Abstract][Full Text] [Related]
46. Reproduction and development.
Spielmann H
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):571-6. PubMed ID: 9599704
[TBL] [Abstract][Full Text] [Related]
47. The effects of chemicals on mammalian fertility. The report and recommendations of ECVAM Workshop 53--the first strategic workshop of the EU ReProTect Project.
Bremer S; Balduzzi D; Cortvrindt R; Daston G; Eletti B; Galli A; Huhtaniemi I; Laws S; Lazzari G; Liminga U; Smitz J; Spano M; Themmen A; Tilloy A; Waalkens-Behrends I
Altern Lab Anim; 2005 Aug; 33(4):391-416. PubMed ID: 16185108
[No Abstract] [Full Text] [Related]
48. Integration of QSAR and in vitro toxicology.
Barratt MD
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):459-65. PubMed ID: 9599692
[TBL] [Abstract][Full Text] [Related]
49. Developing alternatives to systemic toxicity testing approaches.
von Aulock S
ALTEX; 2012; 29(1):1. PubMed ID: 22408846
[No Abstract] [Full Text] [Related]
50. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
Pfuhler S; Kirkland D; Kasper P; Hayashi M; Vanparys P; Carmichael P; Dertinger S; Eastmond D; Elhajouji A; Krul C; Rothfuss A; Schoening G; Smith A; Speit G; Thomas C; van Benthem J; Corvi R
Mutat Res; 2009; 680(1-2):31-42. PubMed ID: 19765670
[TBL] [Abstract][Full Text] [Related]
51. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
52. The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals.
Halle W
Altern Lab Anim; 2003; 31(2):89-198. PubMed ID: 15612878
[TBL] [Abstract][Full Text] [Related]
53. Use and validation of HT/HC assays to support 21st century toxicity evaluations.
Patlewicz G; Simon T; Goyak K; Phillips RD; Rowlands JC; Seidel SD; Becker RA
Regul Toxicol Pharmacol; 2013 Mar; 65(2):259-68. PubMed ID: 23291301
[TBL] [Abstract][Full Text] [Related]
54. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
55. ECVAM and new technologies for toxicity testing.
Bouvier d'Yvoire M; Bremer S; Casati S; Ceridono M; Coecke S; Corvi R; Eskes C; Gribaldo L; Griesinger C; Knaut H; Linge JP; Roi A; Zuang V
Adv Exp Med Biol; 2012; 745():154-80. PubMed ID: 22437818
[TBL] [Abstract][Full Text] [Related]
56. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
[TBL] [Abstract][Full Text] [Related]
57. Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment.
Kyffin JA; Sharma P; Leedale J; Colley HE; Murdoch C; Mistry P; Webb SD
Toxicol In Vitro; 2018 Apr; 48():262-275. PubMed ID: 29408671
[TBL] [Abstract][Full Text] [Related]
58. The necessity of biokinetic information in the interpretation of in vitro toxicity data.
Blaauboer BJ
Altern Lab Anim; 2002 Dec; 30 Suppl 2():85-91. PubMed ID: 12513656
[TBL] [Abstract][Full Text] [Related]
59. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
Phalen RF
Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
[TBL] [Abstract][Full Text] [Related]
60. The OECD health effects test guidelines: a challenge to the sincerity of commitment to the three Rs.
Balls M; Combes RD
Altern Lab Anim; 2006 Feb; 34(1):105-8. PubMed ID: 16522152
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
